Cancer Patients Enrolled in a Smoking Cessation Clinical Trial: Characteristics and Correlates of Smoking Rate and Nicotine Dependence

Overview

Journal J Addict

Date 2018 Apr 24

PMID 29682394

Citations 10

Authors

Andrew Miele

Morgan Thompson

Nancy C Jao

Ravi Kalhan

Frank Leone

Lee Hogarth

Brian Hitsman

Robert Schnoll

Affiliations

Soon will be listed here.

Abstract

Introduction: A substantial proportion of cancer patients continue to smoke after their diagnosis but few studies have evaluated correlates of nicotine dependence and smoking rate in this population, which could help guide smoking cessation interventions.

Aim: This study evaluated correlates of smoking rate and nicotine dependence among 207 cancer patients.

Methods: A cross-sectional analysis using multiple linear regression evaluated disease, demographic, affective, and tobacco-seeking correlates of smoking rate and nicotine dependence. Smoking rate was assessed using a timeline follow-back method. The Fagerström Test for Nicotine Dependence measured levels of nicotine dependence.

Results: A multiple linear regression predicting nicotine dependence showed an association with smoking to alleviate a sense of addiction from the Reasons for Smoking scale and tobacco-seeking behavior from the concurrent choice task ( < .05), but not with affect measured by the HADS and PANAS ( > .05). Multiple linear regression predicting prequit showed an association with smoking to alleviate addiction ( < .05). ANOVA showed that Caucasian participants reported greater rates of smoking compared to other races.

Conclusions: The results suggest that behavioral smoking cessation interventions that focus on helping patients to manage tobacco-seeking behavior, rather than mood management interventions, could help cancer patients quit smoking.

Citing Articles

Systematic Review of Smoking Cessation Interventions for Smokers Diagnosed with Cancer.

Frazer K, Bhardwaj N, Fox P, Stokes D, Niranjan V, Quinn S Int J Environ Res Public Health. 2022; 19(24).

PMID: 36554894 PMC: 9779002. DOI: 10.3390/ijerph192417010.

Feasibility of Patient Navigation-Based Smoking Cessation Program in Cancer Patients.

Fan T, Yingst J, Bascom R, Tuanquin L, Veldheer S, Branstetter S Int J Environ Res Public Health. 2022; 19(7).

PMID: 35409717 PMC: 8998497. DOI: 10.3390/ijerph19074034.

Relative expected value of drugs versus competing rewards underpins vulnerability to and recovery from addiction.

Hogarth L, Field M Behav Brain Res. 2020; 394:112815.

PMID: 32707138 PMC: 7495042. DOI: 10.1016/j.bbr.2020.112815.

Contribution of alcohol- and cigarette-related cues to concurrent reinforcer choice in humans.

Strickland J, Bergeria C Behav Processes. 2020; 176:104124.

PMID: 32305455 PMC: 7283006. DOI: 10.1016/j.beproc.2020.104124.

Addiction is driven by excessive goal-directed drug choice under negative affect: translational critique of habit and compulsion theory.

Hogarth L Neuropsychopharmacology. 2020; 45(5):720-735.

PMID: 31905368 PMC: 7265389. DOI: 10.1038/s41386-020-0600-8.

References

Schnoll R, Martinez E, Tatum K, Weber D, Kuzla N, Glass M . A bupropion smoking cessation clinical trial for cancer patients. Cancer Causes Control. 2010; 21(6):811-20. DOI: 10.1007/s10552-010-9507-8. View

Lopez A, Skelly J, Higgins S . Financial incentives for smoking cessation among depression-prone pregnant and newly postpartum women: effects on smoking abstinence and depression ratings. Nicotine Tob Res. 2015; 17(4):455-62. PMC: 4402351. DOI: 10.1093/ntr/ntu193. View

Hogarth L, Mathew A, Hitsman B . Current major depression is associated with greater sensitivity to the motivational effect of both negative mood induction and abstinence on tobacco-seeking behavior. Drug Alcohol Depend. 2017; 176:1-6. PMC: 5499379. DOI: 10.1016/j.drugalcdep.2017.02.009. View

Hogarth L . Goal-directed and transfer-cue-elicited drug-seeking are dissociated by pharmacotherapy: evidence for independent additive controllers. J Exp Psychol Anim Behav Process. 2012; 38(3):266-78. DOI: 10.1037/a0028914. View

Cox L, Tiffany S, Christen A . Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res. 2001; 3(1):7-16. DOI: 10.1080/14622200020032051. View

Carroll A, Veluz-Wilkins A, Blazekovic S, Kalhan R, Leone F, Wileyto E . Cancer-related disease factors and smoking cessation treatment: Analysis of an ongoing clinical trial. Psychooncology. 2017; 27(2):471-476. PMC: 5958302. DOI: 10.1002/pon.4483. View

Chang E, Braith A, Hitsman B, Schnoll R . Treating Nicotine Dependence and Preventing Smoking Relapse in Cancer Patients. Expert Rev Qual Life Cancer Care. 2017; 2(1):23-39. PMC: 5553981. DOI: 10.1080/23809000.2017.1271981. View

Gritz E, Schacherer C, Koehly L, Nielsen I, Abemayor E . Smoking withdrawal and relapse in head and neck cancer patients. Head Neck. 1999; 21(5):420-7. DOI: 10.1002/(sici)1097-0347(199908)21:5<420::aid-hed7>3.0.co;2-u. View

Ahmed S . Validation crisis in animal models of drug addiction: beyond non-disordered drug use toward drug addiction. Neurosci Biobehav Rev. 2010; 35(2):172-84. DOI: 10.1016/j.neubiorev.2010.04.005. View

10.

Horn D, WAINGROW S . Some dimensions of a model for smoking behavior change. Am J Public Health Nations Health. 1966; 56(12):Suppl 56:21-6. PMC: 1267242. DOI: 10.2105/ajph.56.12_suppl.21. View

11.

Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

12.

Chase H, MacKillop J, Hogarth L . Isolating behavioural economic indices of demand in relation to nicotine dependence. Psychopharmacology (Berl). 2012; 226(2):371-80. DOI: 10.1007/s00213-012-2911-x. View

13.

Hogarth L, Maynard O, Munafo M . Plain cigarette packs do not exert Pavlovian to instrumental transfer of control over tobacco-seeking. Addiction. 2014; 110(1):174-82. PMC: 4309177. DOI: 10.1111/add.12756. View

14.

Heatherton T, Kozlowski L, Frecker R, Fagerstrom K . The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991; 86(9):1119-27. DOI: 10.1111/j.1360-0443.1991.tb01879.x. View

15.

Vander Ark W, DiNardo L, OLIVER D . Factors affecting smoking cessation in patients with head and neck cancer. Laryngoscope. 1997; 107(7):888-92. DOI: 10.1097/00005537-199707000-00010. View

16.

Bloom E, Oliver J, Sutton S, Brandon T, Jacobsen P, Simmons V . Post-operative smoking status in lung and head and neck cancer patients: association with depressive symptomatology, pain, and fatigue. Psychooncology. 2014; 24(9):1012-9. PMC: 4374041. DOI: 10.1002/pon.3682. View

17.

Warren G, Alberg A, Kraft A, Cummings K . The 2014 Surgeon General's report: "The health consequences of smoking--50 years of progress": a paradigm shift in cancer care. Cancer. 2014; 120(13):1914-6. PMC: 5928784. DOI: 10.1002/cncr.28695. View

18.

Simmons V, Litvin E, Jacobsen P, Patel R, McCaffrey J, Oliver J . Predictors of smoking relapse in patients with thoracic cancer or head and neck cancer. Cancer. 2013; 119(7):1420-7. PMC: 3604135. DOI: 10.1002/cncr.27880. View

19.

Mathew A, Hogarth L, Leventhal A, Cook J, Hitsman B . Cigarette smoking and depression comorbidity: systematic review and proposed theoretical model. Addiction. 2016; 112(3):401-412. PMC: 5296249. DOI: 10.1111/add.13604. View

20.

Cox L, Africano N, Tercyak K, Taylor K . Nicotine dependence treatment for patients with cancer. Cancer. 2003; 98(3):632-44. DOI: 10.1002/cncr.11538. View